TrueShares Structured Outcome (August) ETF (AUGZ)
Live price chart, market sentiment, and community perspectives for TrueShares Structured Outcome (August) ETF (CBOE: AUGZ).
Live price chart, market sentiment, and community perspectives for TrueShares Structured Outcome (August) ETF (CBOE: AUGZ).
On our desk, evaluating the Truemark Group's AUGZ comes down to weighing the 0.79% expense ratio against the 10% targeted downside buffer on the SandP 500. While the 3-year historical annualized return of roughly 14.94% looks appealing for a derivative income strategy, the net assets hovering between $28M and $43.7M mean we need to watch liquidity closely, especially with a 30-day median bid/ask spread sitting at 0.20%.
From a risk management standpoint, the structured outcome model utilizing annual resets starting August 1 gives clients a defined window for risk mitigation. However, the operational structure relying on options on the SandP 500 Price Index introduces complexity that retail investors frequently misunderstand, particularly regarding how option pricing caps potential upside during aggressive bull runs.
When analyzing the technical architecture of AUGZ for our quantitative models, we note its classification under Derivative Income and Alternative Strategies on the Cboe BZX exchange. The fund's six holdings reflect a targeted options overlay. Analysts should review the April 30, 2026 Summary Prospectus and periodic Schedule of Investments filings to accurately map the current buffer layers relative to the prevailing SandP 500 index level.
As a bio-analyst transitioning into multi-asset evaluation, I find the structured buffer framework fascinatingly analogous to clinical trial risk mitigation—capping downside losses in exchange for option-based participation limits. Nevertheless, the high 0.80% fee tier requires consistent outperformance or steep market downturns where the buffer activates to justify holding over lower-cost broad index alternatives.
Reviewing the fund details as of mid-2026, with shares outstanding at 945,000 and NAV symbols actively reporting on Cboe BZX, our options desk notes that the 52-week trading range between $39.83 and $46.95 tightly mirrors the underlying SandP 500 trajectory adjusted for the options collar. Execution quality requires limit orders given the 0.20% median bid/ask spread.
Explore plasma cleansing, somatic organ swaps, and BCI.